Property Name | Property Value | Unit | Raw Value | Raw Unit | Reference |
---|---|---|---|---|---|
Water Solubility | 1000.0 | mg/L | <1 | mg/ml | MSDS |
Property Name | Property Value | Unit | Raw Value | Raw Unit | Annotation | Reference |
---|---|---|---|---|---|---|
AUC | 29268.0 | ng.h/ml | 29268.0 | ng.h/ml | DRUGBANK | |
C Max | 1399.0 | ng/ml | 1399 | ng/ml | DRUGBANK | |
T Max | 2.5 | h | 2.5 | h | DRUGBANK | |
Tss | 336.0 | h | 2 | week | DRUGBANK | |
Clearance | 0.36 | L/h | 0.362 | L/h | apparent clearance; | DRUGBANK | Clearance | 0.26 | L/h | 0.26 | L/h | PO, oral; | DRUGBANK |
Volume of Distribution | 27.5 | L | 26-29 | L | Apparent volume of distribution; patients; | DRUGBANK |
Half-life | 59.0 | h | 59 | h | effective half-life; | DRUGBANK | Half-life | 55.0 | h | 50-60 | h | effective half-life; | DRUGBANK |
Eliminate Route | 69.0 | % | 69 | % | Faeces excretion; Oral single dose; | DRUGBANK | Eliminate Route | 19.0 | % | 19 | % | Urinary excretion; Oral single dose; | DRUGBANK | Eliminate Route | 13.1 | % | ~13.11 | % | Faeces excretion; Oral single dose; Unchanged drug; | DRUGBANK | Eliminate Route | 2.5 | % | 2.47 | % | Urinary excretion; Oral single dose; Unchanged drug; | DRUGBANK |
Protein Binding | 99.8 | % | ~99.8 | % | DRUGBANK |
Property Name | Property Value | Unit | Raw Value | Raw Unit | Annotation | Frequency | Brand Name | Component | Reference |
---|---|---|---|---|---|---|---|---|---|
Max dose for adults | 9.0 | mg/day | 9 | mg/day | PO, oral | qd | Balversa | erdafitinib | PDR |
Max dose for geriatric | 9.0 | mg/day | 9 | mg/day | PO, oral | qd | Balversa | erdafitinib | PDR |